SPHK1 and neoplasm: Importantly, it has been demonstrated that several human tumour-derived cell lines become apoptotic when treated with SPHK small-molecule inhibitors, and that their effectiveness can be accounted for by their abilities to reduce S1P levels (Bektas et al, 2005a).